How long does a box of Imatinib (Gleevec) usually last and the treatment schedule?

Imatinib (Imatinib) is an oral tyrosine kinase inhibitor (TKI), mainly used to treat chronic myelogenous leukemia (CML), gastrointestinal stromal tumor (GIST) and other specific leukemias or tumors. Common standard dosages range from 400 mg to 600 mg once daily. The specific dosage needs to be adjusted according to the type of disease, patient weight, liver and kidney function, and tolerance. The tablets are generally swallowed whole and can be taken with food to reduce gastrointestinal irritation.

Imatinib is usually packaged and sold in 100mg specifications. The quantity in a box is generally 120 tablets or 60 tablets. Based on the conventional dosage of 100mg once a day, a box of 120 tablets can be taken for one month, and 60tablets can be taken for half a month. Therefore, when purchasing drugs, patients need to combine their daily dosage with the doctor’s treatment plan and reasonably arrange the purchase cycle to avoid drug shortages or intermittent medication.

The course of imatinib treatment is usually long-term maintenance treatment, especially for patients in the chronic phaseCML. Most patients need to continue taking the drug for several years or even lifelong to maintain disease remission and prevent recurrence. In the early stage of treatment, hematology tests and molecular biology monitoring are generally performed every 3 months. The dosage or course of treatment is adjusted based on the blood picture and BCR-ABL fusion gene levels. For patients with gastrointestinal stromal tumors, the length of treatment needs to be determined based on the risk of recurrence after surgery and pathological classification, which is generally one year or longer.

When taking imatinib for a long time, patients should regularly monitor blood routine, liver and kidney function and electrocardiogram, and pay attention to possible side effects, such as edema, rash, fatigue and gastrointestinal discomfort. If obvious discomfort or abnormal blood indicators occur, timely feedback should be reported to the doctor so that the dose can be adjusted or the medication can be temporarily discontinued. Reasonable arrangement of medication dosage and treatment course not only helps to improve treatment compliance, but also ensures the efficacy and medication safety to the greatest extent.

Reference materials:https://www.drugs.com/